Mettler-Toledo International Inc. (NYSE:MTD) Stock Holdings Trimmed by Oak Thistle LLC

Oak Thistle LLC lowered its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 80.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 223 shares of the medical instruments supplier’s stock after selling 947 shares during the period. Oak Thistle LLC’s holdings in Mettler-Toledo International were worth $297,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in MTD. Capital International Investors raised its stake in shares of Mettler-Toledo International by 3.0% in the 4th quarter. Capital International Investors now owns 933,989 shares of the medical instruments supplier’s stock worth $1,132,891,000 after buying an additional 27,386 shares in the last quarter. Morgan Stanley raised its stake in shares of Mettler-Toledo International by 9.6% in the 3rd quarter. Morgan Stanley now owns 267,167 shares of the medical instruments supplier’s stock worth $296,041,000 after buying an additional 23,305 shares in the last quarter. Norges Bank bought a new stake in shares of Mettler-Toledo International in the 4th quarter worth $320,847,000. Principal Financial Group Inc. raised its stake in shares of Mettler-Toledo International by 65.4% in the 4th quarter. Principal Financial Group Inc. now owns 241,219 shares of the medical instruments supplier’s stock worth $292,589,000 after buying an additional 95,421 shares in the last quarter. Finally, PineStone Asset Management Inc. raised its stake in shares of Mettler-Toledo International by 29.4% in the 4th quarter. PineStone Asset Management Inc. now owns 197,182 shares of the medical instruments supplier’s stock worth $239,174,000 after buying an additional 44,847 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Insider Activity at Mettler-Toledo International

In related news, Director Thomas P. Salice sold 1,268 shares of the business’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $1,490.18, for a total transaction of $1,889,548.24. Following the transaction, the director now directly owns 244 shares in the company, valued at $363,603.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Thomas P. Salice sold 1,268 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $1,490.18, for a total value of $1,889,548.24. Following the sale, the director now directly owns 244 shares in the company, valued at approximately $363,603.92. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Christian Magloth sold 1,100 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $1,470.97, for a total value of $1,618,067.00. Following the completion of the sale, the insider now owns 734 shares in the company, valued at $1,079,691.98. The disclosure for this sale can be found here. Insiders have sold 3,278 shares of company stock worth $4,871,849 over the last three months. Company insiders own 1.94% of the company’s stock.

Analyst Upgrades and Downgrades

MTD has been the topic of a number of research reports. Jefferies Financial Group reissued an “underperform” rating and issued a $1,250.00 price objective (up previously from $1,230.00) on shares of Mettler-Toledo International in a research note on Monday, June 3rd. Robert W. Baird lifted their target price on Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the stock a “neutral” rating in a report on Monday, May 13th. Evercore ISI lifted their target price on Mettler-Toledo International from $1,200.00 to $1,300.00 and gave the stock an “in-line” rating in a report on Thursday, April 4th. StockNews.com upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Monday, April 29th. Finally, Citigroup lifted their target price on Mettler-Toledo International from $975.00 to $1,200.00 and gave the stock a “sell” rating in a report on Monday, May 13th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $1,256.25.

Mettler-Toledo International Price Performance

Shares of NYSE MTD traded down $30.75 during trading hours on Monday, hitting $1,366.84. 149,568 shares of the company’s stock were exchanged, compared to its average volume of 146,865. Mettler-Toledo International Inc. has a 1-year low of $928.49 and a 1-year high of $1,535.86. The stock has a market capitalization of $29.20 billion, a price-to-earnings ratio of 38.33, a PEG ratio of 3.75 and a beta of 1.17. The company’s 50-day moving average price is $1,399.77 and its 200-day moving average price is $1,294.18.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $8.89 earnings per share for the quarter, topping the consensus estimate of $7.61 by $1.28. Mettler-Toledo International had a negative return on equity of 662.32% and a net margin of 20.55%. The business had revenue of $925.95 million during the quarter, compared to analysts’ expectations of $879.72 million. During the same quarter in the previous year, the firm earned $8.69 EPS. The firm’s revenue was down .3% compared to the same quarter last year. On average, research analysts expect that Mettler-Toledo International Inc. will post 40.13 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.